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Edited by Horst FeldmannAbstract Cellular ageing is characterized by the accumulation
of oxidatively modiﬁed proteins which may be due to increased
protein damage and/or decreased elimination of oxidized protein.
Since the proteasome is in charge of protein turnover and re-
moval of oxidized protein, its fate during ageing and upon oxida-
tive stress has received special attention, and evidence has been
provided for an age-related impairment of proteasome function.
However, proteins when oxidized at the level of sulfur-containing
amino acids can also be repaired. Therefore, the fate of the
methionine sulfoxide reductase system during ageing has also
been addressed as well as its role in protection against oxidative
stress.
 2006 Federation of European Biochemical Societies. Published
by Elsevier B.V. All rights reserved.
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Reactive oxygen species-mediated damage to cellular com-
ponents is believed to be a main contributor to the ageing pro-
cess [1,2]. Oxidized protein build up represents a hallmark of
cellular ageing, a process that results, at least in part from a
failure of protein maintenance [3,4]. Indeed, the age-related
accumulation of oxidized protein has been proposed to be
due to either or both increased protein oxidative damage and
decreased oxidized protein degradation and repair (see
Fig. 1). In the cytosol and the nucleus, the proteasome has
been described as the main intracellular proteolytic pathway
implicated in both the degradation of oxidized proteins and
the general turnover of proteins [5,6], while the Lon protease
has been shown to selectively degrade oxidized proteins within
the mitochondrial matrix [7]. More recently, chaperone-medi-
ated autophagy has also been shown to be activated upon oxi-
dative stress [8]. Beside degradation, certain types of protein
oxidative damage aﬀecting sulfur-containing amino acids have
been found to be reversible, hence leading to the possibility
that some oxidized proteins could be repaired [9,10]. Indeed,
several oxidation products of methionine and cysteine, that
are among the most susceptible amino acids to oxidative mod-*Fax: +33 0 1 44 27 82 34.
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doi:10.1016/j.febslet.2006.03.028iﬁcation, can be reversed by dedicated enzymatic systems. Thi-
oredoxin/thioredoxin reductase and glutaredoxin/glutathione/
glutathione reductase can reverse the oxidation of disulﬁde
bridges and cysteine sulfenic acids [10], while methionine sulf-
oxide reductases catalyze the reduction of methionine sulfox-
ide back to methionine within proteins [9]. An age-related
impairment of oxidized protein elimination (i.e., degradation
and repair) would therefore be expected to aﬀect intracellular
protein homeostasis and to promote accumulation of oxida-
tively modiﬁed protein. In this minireview, the fate of these
oxidized protein degradation and repair systems during ageing
and upon oxidative stress will be addressed as well as their con-
tribution to protection against oxidative stress. Understanding
the mechanisms by which these crucial protein maintenance
systems are aﬀected during ageing may open new strategies
for delaying ageing and increasing cellular resistance to oxida-
tive stress.2. Reversible and irreversible protein oxidative damage
Protein oxidation results from the reaction of reactive oxy-
gen species (superoxide, hydrogen peroxide, and hydroxyl rad-
ical) and reactive nitrogen species (nitric oxide and
peroxynitrite) with both amino acid side chains and peptidic
backbone [2]. Such reactive species are produced endoge-
neously by intracellular aerobic metabolism, specially at the
peroxisome and the mitochondria level [1]. In addition, the
production of reactive oxygen/nitrogen species can be pro-
moted by diﬀerent oxidative stress (UV irradiation, inﬂamma-
tion, ischemia–reperfusion, etc). Upon oxidative stress or
under physiopathological conditions, an increased production
of reactive oxygen/nitrogen species will disrupt the cellular re-
dox homeostasis and provoke damage to cellular components
(lipids, nucleic acids, and proteins). Oxidative damage to pro-
teins can virtually aﬀect all amino acids, sulfur-containing ami-
no acids and aromatic amino acids being the most susceptible
to oxidation [2] . Interestingly, certain oxidation products of
cysteine and methionine are reversible since they can be
brought back to the reduced form of the amino acid within
proteins by speciﬁc enzymatic systems which correspond to
oxidized protein repair enzymes [9,10].
Concerning cysteine oxidation products, the thioredoxin/thi-
oredoxin reductase system has been implicated in the reduction
of disulﬁde bridges and cystein sulfenic acid, while both
disulﬁde bridges and low molecular mixed disulﬁdes such as
glutathione adducts are reduced by the glutaredoxin/glutathi-blished by Elsevier B.V. All rights reserved.
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aredoxin are small ubiquitous proteins belonging to the
thiol/disulﬁde oxidoreductase family, the members of which
contain a redox active center made of two cysteins that can
form a disulﬁde bridge upon oxidation. Oxidized thioredoxin
is then reduced by thioredoxine reductase, a selenocysteine
and ﬂavin containing enzyme, in a NADPH dependant man-
ner, while oxidized glutaredoxin is reduced by glutathione
reductase also in a NADPH dependent manner. Interestingly,
in eukaryotes, both thioredoxin/thioredoxin reductase and
glutaredoxin/glutathione/glutathione reductase system are
present in the cytosol and the mitochondria and have long
been recognized to be involved not only in oxidized protein re-
pair but also in cellular protection against oxidative stress as
well as in redox signalling process [10]. Moreover, the oxida-
tive inactivation of thioredoxin-dependent peroxidases, perox-
iredoxins, has been shown to be reversible in mammalian cells
and the reversion of cysteine-sulﬁnic acid, resulting from
hyperoxidation of peroxiredoxins, back to reduced cystein
has been recently documented to be carried out in an ATP-
and thioredoxin-dependent manner by speciﬁc and yet unex-
plored enzymes, sulﬁredoxin and sestrins [11,12]. Oxidation
of methionine residues in proteins has been shown to contrib-
ute to the impairment of protein function and in the loss of
their activity. In fact methionine residues in proteins can be
oxidized in methionine S and R sulfoxide diastereoisomeric
forms that can be catalytically reversed by the peptide methio-
nine sulfoxide enzymes, MsrA and MsrB, respectively, allow-
ing in some cases the recovery of the protein function [13].
In eukaryotes, MsrA is expressed from a single gene and is
found in almost all cellular types in the cytosol as well as in
the mitochondria [14,15] and in the nucleus of mouse cells
[16]. MsrB enzymes are encoded by three diﬀerent genes and
their products are designated as MsrB1 (SelX), a selenoprotein
which is present in the nucleus and the cytosol, MsrB2 (Cbs-1)
which is localized in the mitochondria and MsrB3A/B, gener-
ated by alternative splicing, that are targeted to the reticulum
endoplasmic and to the mitochondria, respectively [17]. Msr
enzymes, especially MsrA, were described as very important
oxidized protein repair systems and as an anti-oxidant enzymes
through the catalyzed reversion of oxidized exposed methio-
nines in proteins, hence contributing to the regulation of the
cellular redox homeostasis [18].
Irreversible oxidation products of other amino acids are
most frequently hydroxylated and carbonylated amino acid
derivatives and detection of protein associated carbonyls rep-
resents a usual way of assessing protein oxidation after
carbonyl derivatization by dinitrophenyl hydrazine [19]. Oxi-
dized proteins are generally less active, less thermostable and
are exposing hydrophobic amino acids at their surface. In
addition, protein damage can result from protein adduct for-
mation with lipid peroxidation products such 4-hydroxy-2-
nonenal and from oxidation of glycation products leading to
the formation of glycoxidation adducts such as pentosidine
or carboxymethyllysine [2]. These latter modiﬁcations often
bring carbonyl groups and/or cross-links within the protein.
In the cytosol, oxidized proteins have been shown to be prefer-
entially degraded by the 20S proteasome in an ATP- and ubiq-
uitin-independent manner [6,20] although other studies have
shown that the ubiquitin-26S proteasome pathway can also
be implicated in the degradation of oxidized proteins [21].
Moreover, upon oxidative stress chaperone-mediated autoph-agy has been recently shown to participate to the accelerated
degradation of oxidized proteins carrying a KFERQ motif [8].
The 20S proteasome is a high molecular weight multienzy-
matic proteolytic complex consisting of a catalytic core that
interacts with a variety of regulators such as PA 700 (to form
the 26S proteasome) or PA 28 [5,22]. The proteasome, which is
present in the archebacteria and in the nucleus and the cytosol
of eukaryotic cells, is made up of four stacked rings of seven
subunits. The apical rings are formed with a-type subunits
while the inner rings are formed with b-type subunits that
are carrying the proteolytic activities. Interestingly, in the
eukaryotic version of the proteasome only three b-type sub-
units possess the N-terminal active site threonine [23]. The
peptidylglutamyl peptide hydrolase activity, that cleaves after
acidic amino acids, is carried by the b1 subunit, the trypsin-like
activity, that cleaves after basic amino acids, is carried by the
b2 subunit and the chymotrypsin-like activity, that cleaves
after hydrophobic and aromatic amino acids, is carried by
the b5 subunit. Upon c-interferon stimulation, these catalytic
subunits can be replaced by inducible subunits ib1, ib2 and
ib5 to form the so-called immunoproteasome which exhibits
higher chymotrypsin-like and trypsin-like activities and lower
peptidylglutamyl peptide hydrolase activity [24,25]. Oxidized
proteins represent good substrates for the 20S proteasome un-
less they become heavily oxidized and cross-linked [26]. In such
a situation, not only these highly damaged proteins become
resistant to proteolysis by the proteasome but they can also
act as inhibitors as clearly demonstrated for proteins cross-
linked after modiﬁcation by the lipid peroxidation product 4-
hydroxy-2-nonenal [27,28].
Mitochondria are the major source of intracellular reactive
oxygen species and they are also one of the main targets for
reactive oxygen species induced damage. In the mitochondria,
oxidized protein degradation has been shown to be achieved
by the ATP-stimulated Lon protease which is homologous to
the oligomeric bacterial Lon protease [29]. Indeed, Davies
and coworkers have shown that the oxidant-sensitive Krebs
cycle enzyme aconitase, when oxidatively damaged, is de-
graded by the Lon protease in an ATP-stimulated fashion
[7]. In the same study, treatment with anti sense oligonucleo-
tides in WI-38 human lung ﬁbroblasts resulted in decreased
Lon protease content and activity while causing an accumula-
tion of oxidatively modiﬁed aconitase.3. Impaired removal of oxidized proteins during ageing
Age-related impairment of proteasome function has been
evidenced in a wide range or organs or cell types [4]. Such a
decline of proteasome activity would therefore be expected
to promote the accumulation of oxidized protein with age. In-
deed, as ﬁrst shown by us for the peptidylglutamyl peptide
hydrolase activity of proteasome puriﬁed from rat liver [30],
an age-related decrease of at least certain proteasome pepti-
dase activities, has been since reported for human keratino-
cytes, human ﬁbroblasts, human eye lens, human
lymphocytes, rat liver, rat cardiomycytes, rat brain and rat
skeletal muscle [31–42]. Our initial ﬁnding of decreased pept-
idylglutamyl peptide hydrolase activity of proteasome puriﬁed
from the liver of old rats was in favor of its speciﬁc inactiva-
tion. Further analyses comparing the 2D gel electrophoresis
patterns of proteasome subunits were indicative of either
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Fig. 1. Intracellular degradation and repair of oxidized proteins. Following protein oxidative damage, oxidized proteins are either degraded or
repaired depending on whether the damage is reversible or not. Age-related accumulation of oxidized and aggregated proteins is therefore dependent
on the balance between oxidative modiﬁcation of proteins and oxidized protein elimination through repair and degradation.
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[31,43,44]. More recently, an increased load of modiﬁcations
by the lipid peroxidation product 4-hydroxy-2-nonenal and
the glycoxidation adduct carboxymethyllysine, for speciﬁc
20S proteasome subunits was found associated with the age-re-
lated decline of 26S proteasome chymotrypsin-like activity
puriﬁed from human peripheral blood lymphocytes [32]. In-
creased modiﬁcation of proteasome b-subunits by 4-hydroxy-
2-nonenal was also reported to be associated with decreased
proteasome activity in the spinal cord of aged rats [37], while
an age-related increased modiﬁcation of the proteasome by
glycoxidation was observed in human lens [42]. In addition
to increased modiﬁcation of proteasome with age, a decreased
proteasome subunit expression has been documented in hu-
man keratinocytes, human ﬁbroblasts, rat cardiomyocytes
and rat spinal cord [31,34,37,39]. Interestingly, ﬁbroblasts
from healthy centenarians exhibited a sustained proteasome
subunit expression and proteolytic activity which were close
to the levels obtained with the young individuals, suggesting
that a preserved proteasome function may have contributed
to the longevity of these individuals [33]. Transcriptome anal-
yses of both human dermal ﬁbroblasts and mouse skeletal
muscle have pointed out an age-related decreased expression
of several 20S and 26S proteasome subunits [45,46]. In the
mouse model, dietary restriction was shown to reverse this
downregulation, implying that the anti ageing eﬀects of dietary
restriction could be explained, at least in part, by stimulation
of protein turnover and elimination of macromolecular dam-
age [45]. More recently, the expression of only b catalytic 20
S proteasome subunits was found to be decreased in senescent
human WI 38 ﬁbroblasts leading to the presence of free a sub-
units and less assembled proteasome [34]. In the same study,
partial inhibition of the proteasome in young WI 38 ﬁbroblasts
for two weeks was found to induce a senescent-like phenotype.
Finally, in aged rat skeletal muscle, the decreased proteasome
activity was attributed to a reduced ability of both PA 28 and
PA 700 regulators to bind to the proteasome, while immuno-
proteasome and constitutive proteasome content were, respec-tively, increased and decreased [35]. Beside direct inactivation
of the proteasome and decreased proteasome subunits expres-
sion, highly modiﬁed and cross-linked proteins, that have been
shown to accumulate with ageing, have been implicated in the
inhibition of proteasome activity [27,28,47]. Indeed, a decline
of proteasome peptidase activities was observed upon loading
of ﬁbroblasts with artiﬁcial lipofuscin [48]. In addition, protea-
some peptidase activities that were strongly inhibited in heart
homogenates from old rats were partially recovered upon puri-
ﬁcation of the proteasome, strongly suggesting the presence of
endogeneous inhibitors in the homogenates that were removed
during proteasome puriﬁcation [31]. Thus, decline of protea-
some activity with age is dependant on at least three diﬀerent
inhibition mechanisms: direct inactivation of the proteasome
through subunit modiﬁcation, decreased expression of certain
proteasome subunits and increased presence of endogenous
inhibitors such as cross-linked proteins.
As for the mitochondrial oxidized protein status and the fate
of the Lon protease during ageing, we have reported an age-re-
lated accumulation of oxidized and glycoxidized proteins in
the liver mitochondrial matrix of rats and a considerable de-
crease of the ATP-stimulated Lon-like proteolytic activity in
27-month-old rats [49]. This decline of ATP-stimulated Lon-
like proteolytic activity was not associated with a concomitant
decrease in the level of Lon protein expression suggesting that
the Lon protease activity is getting either inhibited or inacti-
vated. However, this decline in Lon protease activity was
found to be associated with a decrease in the activity of mito-
chondrial aconitase [50], an essential Krebs’cycle enzyme
known to be very sensitive to oxidative inactivation in mam-
malian mitochondria. An age-related decline of both Lon gene
and protein expression has been documented in mouse skeletal
muscle [45,51]. Interestingly, this decline in gene expression
was completely prevented when the animals were subjected
to dietary restriction, the only intervention known to retard
ageing in mammals [45]. Finally, contrary to what we observed
in the liver and what was previously observed in mouse skeletal
muscle, the ATP-stimulated protease activity was found to re-
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ing, and the levels of expression of the Lon protease increased
in the older animals in comparison with the younger ones [50].
These results indicate that matrix proteins such as the critical
enzymes aconitase and Lon protease are getting inactivated
with ageing and that the eﬀects of ageing on the Lon protease
vary from one organ to another.
Concerning oxidized repair systems, we have shown that, in
rat organs in which MsrA is particularly abundant, i.e., liver,
kidney, and brain, peptide methionine sulfoxide reductase
activity is notably reduced during ageing [52]. This is related
to a decrease in MsrA gene expression in liver and kidney.
In contrast, in the brain, the diﬀerences in gene expression were
not statistically signiﬁcant and the MsrA protein level was re-
duced only in 26-month-old rats at the very end of the life of
the animals. This intriguing observation may now be explained
in light of the existence, in addition to MsrA, of several MsrB
genes encoding at least four proteins in mammalian cells.
Although MsrB2 (Cbs-1) is not abundant in brain, the other
MsrB could be responsible for the alteration in peptide methi-
onine sulfoxide reductase activities determined during brain
ageing. The status of the peptide methionine sulfoxide reduc-
tases system was also analyzed in WI-38 human ﬁbroblasts
during cellular senescence [53]. Total peptide methionine sulf-
oxide reductase activity was tested by monitoring the reduction
of the synthetic substrate N-acetyl(3H)MetR,S(O) to N-ace-
tyl(3H)MetR,S, which can be reduced by either MsrA or
MsrB. A decreased peptide methionine sulfoxide reductase
activity was observed in senescent cells, that correlated with
a decrease in both MsrA and MsrB2 (Cbs-1) gene expression.
Impaired expression and/or activity of the peptide methionine
sulfoxide reductases system may therefore explain an accumu-
lation of unrepaired proteins, and might contribute to the age-
related accumulation of oxidized proteins.4. Protein maintenance and protection against oxidative stress
To gain better insights in the relationship between oxidized
protein removal and cellular resistance against oxidative stress,
the eﬀects of oxidative stress on repair and degradation systems
have been investigated as well as the inﬂuence of increased pro-
tein degradation and repair on cellular protection against oxi-
dative stress. Thus, the proteasome has been evidenced as a
target for modiﬁcation by oxidation and related pathways
in vivo. Following the demonstration that the proteasome
can be inactivated by iron catalyzed oxidation in vitro, treat-
ment of FAO hepatoma cells with iron and ascorbate resulted
in the impairment of proteasome peptidylglutamyl peptide
hydrolase and trypsin-like activities [54]. Interestingly, overex-
pression of chaperone proteins such as Hsp 90 or HDJ-1 was
found to exert protection against inactivation of the protea-
some following oxidative insults to FAO hepatoma cells and
neural SH-SY5Y cells, respectively [54,55]. Moreover,
treatment of kidney with ferryl nitriloacetate and brain ische-
mia–reperfusion were associated with decreased proteasome
function and modiﬁcation of the proteasome by the lipid perox-
idation product 4-hydroxy-2-nonenal [56,57]. Speciﬁc modiﬁ-
cation of three proteasome subunits by 4-hydroxy-2-nonenal
was also associated with inactivation of the trypsin-like activity
upon cardiac ischemia–reperfusion [58]. In addition, we have
recently found that in vitro treatment of proteasome puriﬁedfrom rat heart results in the preferential inactivation of the
trypsin-like activity and the modiﬁcation of restricted set of
proteasome subunits that include those previously reported to
be targeted upon ischemia–reperfusion, hence making 4-hydro-
xy-2-nonenal modiﬁcation of proteasome as a likely mecha-
nism for proteasome inactivation in vivo [59]. UV irradiation
of human keratinocyte also results in a decline of proteasome
peptidase activities that has been primarily associated with
the build-up of damaged proteins, including proteins modiﬁed
by 4-hydroxy-2-nonenal [47]. Since low molecular weight com-
pounds such as certain fatty acids have been shown to stimulate
proteasome activity in vitro, we have assayed plant and algae
extracts for their ability to stimulate proteasome activity in
keratinocyte cultures. We have found that a fatty acid-rich ex-
tract from the algae Phaeodactylum tricornutum was able to
stimulate the proteasome peptidase activities both in vitro
and in cultured keratinocytes and to reduce the level of oxidized
proteins after UV irradiation [60]. Therefore, treatment with
such a proteasome stimulating agent may represent not only
an eﬃcient strategy for an increased protection against oxida-
tive stress but also for developing anti-ageing strategies. Inter-
estingly, Chondrogianni et al. have recently found that stable
overexpression of either b1 or b5 in SV40T/WI 38 ﬁbroblasts
and HL 60 resulted in an increased ability of these cells to cope
with diﬀerent oxidative stress through increased rates of prote-
olysis and decreased oxidized protein content [61]. Moreover,
normal IMR 90 ﬁbroblasts transfected by the b5 proteasome
subunit exhibited an increased lifespan as demonstrated by an
extension of their the replicative potential of 4–5 population
doublings [61].
The peptide methionine sulfoxide reductases system has also
been implicated in increased longevity and resistance to oxida-
tive stress. Using knockout mice and transgenic Drosophila
respectively, Stadtman and Hoshi laboratories [62,63] have ad-
dressed the role of MsrA in lifespan regulation related to the
antioxidant properties of the enzyme. In transgenic Drosophila,
overexpression of MsrA extended the mean lifespan by up to
70% and the ﬂies exhibited higher resistance to paraquat-
induced oxidative stress [63]. In contrast, mice lacking the
msrA gene were more sensitive to oxidative stress, showed
an accumulation of oxidized proteins and had a 40% shorter
lifespan [62]. We have reported that both MsrA and MsrB
(Cbs-1) are upregulated in WI 38 ﬁbroblasts when challenged
with low concentration of hydrogen peroxide, hence suggesting
an important role of the methionine sulfoxide reductase system
in cellular stress defense [53]. In PC 12 neuronal cells, overex-
pression of MsrA was found to exert a protective eﬀect against
oxidative injury by reducing the level of reactive oxygen species
after hypoxia/reoxygenation [64]. The same behaviour was ob-
served in MsrA overexpressing human lens epithelial cells
when exposed with hydrogen peroxide while MsrA gene silenc-
ing was associated with an increased sensitivity to oxidative
stress [65]. Such a protective role against oxidative stress was
also observed for MsrB in human lens cells since the silencing
of one or all MsrB genes was accompanied with increased oxi-
dative stress-induced cell death [66]. We have recently shown
that overexpression of MsrA in SV40T/WI 38 ﬁbroblasts led
to an increased protection against cell death induced by hydro-
gen peroxide mediated oxidative stress and found that this in-
creased protection was resulting from a decreased level of
intracellular reactive oxygen species and an almost total pro-
tection against formation of protein oxidative damage [67].
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treatment with anti sense oligonucleotides inWI-38 human lung
ﬁbroblasts resulted in decreasedLon protease content and activ-
ity while causing an accumulation of oxidatively modiﬁed acon-
itase [7]. Moreover, using transgenic mice under-expressing
mitochondrial superoxide dismutase as a model of oxidatively
challenged animals, Bota et al. reported a decreased Lon prote-
ase protein level and this Lon deﬁciency was associated with in-
creased levels of oxidized proteins [51].More recently, Bota et al.
have also shown that down regulation of the human Lon prote-
ase results in the impairment of mitochondrial structure and
function and causes cell death, with the majority of cells under-
going caspase 3 activation and apoptosis within four days [68].
Electron microscopy performed on Lon-deﬁcient cells revealed
aberrant mitochondrial morphology and the presence electron
dense inclusion bodies in the mitochondrial matrix thought to
be caused by aggregated proteins. Although to our knowledge,
the eﬀects of overexpression of the Lon protease in mammalian
cells have not yet been documented, an activation of the ATP-
stimulated mitochondrial protease has been recently reported
following cardiac ischemia–reperfusion [69], suggesting an
important role of the Lon protease in the removal of oxidized
proteins and mitochondrial protein homeostasis.5. Concluding remarks
Protein maintenance and especially oxidized protein degra-
dation and repair systems appears to play a critical role in cell
survival and homeostasis, as demonstrated by the impact of
improved protein degradation and repair on longevity and/or
resistance to oxidative stress. Conversely, decreased protein
degradation and repair has been associated to an increased
susceptibility to oxidative stress. On the other hand, as illus-
trated by the now well-established impairment of proteasome
function with age and by more recent data on the age-related
decline of other protein degradation and repair systems such
as the mitochondrial Lon protease and the repair enzymes
methionine sulfoxide reductases, protein maintenance failure
represents a characteristic feature of cellular ageing that partic-
ipates to the age-related intracellular build-up of oxidized and
aggregated proteins. Understanding the implication and the
complex interactions of these systems in cellular protein and
redox homeostasis represents an obligatory step as to whether
they can be used as valuable handle for slowing down ageing.
Importantly, deciphering the molecular mechanisms that con-
tribute to the age-related impairment of protein maintenance
systems is likely to provide valuable information that ulti-
mately may lead to the development of anti-ageing strategies
aimed at promoting healthy ageing.
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